Literature DB >> 16961813

Monoclonal gammopathy of undetermined significance and Russell body formation in Helicobacter pylori gastritis.

Gernot W Wolkersdörfer1, Michael Haase, Andrea Morgner, Gustavo Baretton, Stephan Miehlke.   

Abstract

BACKGROUND: Infection by Helicobacter pylori has been linked to monoclonal gammopathy of undetermined significance (MGUS). MGUS is thought to develop due to chronic antigenic stimulation in people with a specific genetic predisposition. METHODS AND
RESULTS: We describe a patient presenting with dyspepsia associated with H. pylori-related erosive gastritis. Histopathologic findings revealed infiltration with plasma cells containing accumulated condensed intercisternal immunoglobulins, the so-called 'Russell bodies'. In addition, MGUS was present with total immunoglobulins within the normal range but a significantly decreased serum concentration of IgG subtype 3. Molecular analyses demonstrated IgH formation, T-cell receptor gamma rearrangement, and alterations within the IgHG3 gene sequence. Following H. pylori eradication, gastritis and dyspepsia gradually resolved but MGUS persisted for at least 22 months.
CONCLUSIONS: This is the first report to demonstrate that upon infection with H. pylori, an impaired secretory capacity of plasma cells due to specific molecular changes can present as Russell body gastritis. The molecular findings question a pathogenetic link between Russell bodies and H. pylori, but suggest genetic alterations in the immunoglobulin locus as the possible cause for both MGUS and Russell body gastritis.

Entities:  

Mesh:

Year:  2006        PMID: 16961813     DOI: 10.1111/j.1523-5378.2006.00443.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  12 in total

1.  Helicobacter pylori-negative Russell body gastritis: case report.

Authors:  Alessandro Del Gobbo; Luca Elli; Paola Braidotti; Franca Di Nuovo; Silvano Bosari; Solange Romagnoli
Journal:  World J Gastroenterol       Date:  2011-03-07       Impact factor: 5.742

2.  Helicobacter pylori-negative Russell body gastritis: does the diagnosis call for screening for plasmacytic malignancies, especially multiple myeloma?

Authors:  Jagpal Singh Klair; Mohit Girotra; Aneet Kaur; Farshad Aduli
Journal:  BMJ Case Rep       Date:  2014-03-26

Review 3.  Hematologic manifestations of Helicobacter pylori infection.

Authors:  Germán Campuzano-Maya
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

4.  Russell body duodenitis with immunoglobulin kappa light chain restriction.

Authors:  William R Munday; Lucy Harn Kapur; Mina Xu; Xuchen Zhang
Journal:  World J Gastrointest Endosc       Date:  2015-01-16

5.  Russell body gastritis with Dutcher bodies evaluated using magnification endoscopy.

Authors:  Kenji Yorita; Takehiro Iwasaki; Kunihisa Uchita; Naoto Kuroda; Koji Kojima; Shinichi Iwamura; Yutaka Tsutsumi; Akinobu Ohno; Hiroaki Kataoka
Journal:  World J Gastrointest Endosc       Date:  2017-08-16

Review 6.  Rare Gastric Lesions Associated with Helicobacter pylori Infection: A Histopathological Review.

Authors:  Mee Joo
Journal:  J Pathol Transl Med       Date:  2017-06-05

Review 7.  Helicobacter pylori and extragastric diseases: A review.

Authors:  Antonietta Gerarda Gravina; Rocco Maurizio Zagari; Cristiana De Musis; Lorenzo Romano; Carmelina Loguercio; Marco Romano
Journal:  World J Gastroenterol       Date:  2018-08-07       Impact factor: 5.742

8.  Russell body gastritis.

Authors:  J Qiao; E Dudrey; S Gilani
Journal:  Pathologica       Date:  2019-06

9.  Two Cases of Russell Body Gastritis Treated by Helicobacter pylori Eradication.

Authors:  Jung Bin Yoon; Tae Yeong Lee; Jin Sook Lee; Jong Min Yoon; Se Won Jang; Min Jung Kim; Su Jin Lee; Tae Oh Kim
Journal:  Clin Endosc       Date:  2012-11-30

10.  Russell body gastroenteritis: an aberrant manifestation of chronic inflammation in gastrointestinal mucosa.

Authors:  Feriyl Bhaijee; Keith A Brown; Billy W Long; Alexandra S Brown
Journal:  Case Rep Med       Date:  2013-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.